Fluvastatin therapy improves microcirculation in patients with hyperlipidaemia.

Area of Science:

• Cardiovascular Medicine
• Pharmacology

Background:

• Hyperlipidaemia poses risks to microcirculatory function.
• Dietary control is often insufficient for managing hyperlipidaemia.
• Microvascular impairment contributes to cardiovascular complications.

Purpose of the Study:

• To evaluate the impact of fluvastatin on microcirculation in hyperlipidaemic patients.
• To assess fluvastatin's efficacy in patients with inadequately controlled cholesterol levels.
• To investigate fluvastatin's effects on both nutritive and thermoregulatory capillaries.

Main Methods:

• Double-blind, placebo-controlled study.
• Inclusion of hyperlipidaemic patients (LDL-C > 160 mg/dL, TG < 350 mg/dL).
• Assessment of microcirculation using capillary microscopy and laser Doppler fluxmetry at the nailfold.
• Fluvastatin 40 mg BID vs. placebo for 12 weeks post-dietary run-in.

Main Results:

• Fluvastatin significantly reduced time to peak flow during postocclusive reactive hyperaemia (P < 0.0001).
• Capillary microscopy indicated improved microcirculatory function with fluvastatin therapy.
• Laser Doppler fluxmetry confirmed enhanced microcirculation in thermoregulatory capillaries.
• Significant reductions in total and LDL-cholesterol were observed.

Conclusions:

• Fluvastatin therapy effectively improves microcirculation in hypercholesterolaemic patients.
• Enhancements in microcirculation were evident within six weeks of fluvastatin treatment.
• Fluvastatin demonstrates benefits for both nutritive and thermoregulatory capillary function.